Pfizer, German institute wrangle over effectiveness of Lipitor

09/6/2005 | MarketWatch

Pfizer Deutschland, Pfizer's German unit, took issues with a study released over the weekend saying Lipitor was no more effective than other statins and caused worse side effects in some cases. An independent German institute issued the report, but Pfizer insisted its drug had fewer side effects than other cardiovascular drugs.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations